← Back
$AGIO All transactions

AGIOS PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$0

Shares

12,750

Price

$0

Filed

Jun 26

Insider

Name

Goff Brian

Title

Chief Executive Officer

CIK

0001546216

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-24

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

12,750

Footnotes

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated August 8, 2022. | Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's performance share unit agreement dated March 1, 2023. | Each performance share unit represents a contingent right to receive one share of the issuer's common stock. | The PSUs were granted on August 8, 2022. The PSUs vest as to 15% of the underlying shares upon the achievement of a specified research milestone and as to the remaining underlying shares upon the achievement of other clinical and regulatory milestones. The performance criteria for the specified research milestone was determined to have been met on June 24, 2025, resulting in the vesting of the PSUs as to 15% of the underlying shares of common stock. Vested shares will be delivered to the reporting person within three business days after such shares become vested. | The PSUs were granted on March 1, 2023. The PSUs vest as to 50% of the underlying shares upon the achievement of a specified research milestone and as to the remaining 50% of the underlying shares upon the achievement of a specified regulatory milestone. The performance criteria for the specified research milestone was determined to have been met on June 24, 2025, resulting in the vesting of the PSUs as to 50% of the underlying shares. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Filing Info

Accession No.

0001439222-25-000063

Form Type

4

Issuer CIK

0001439222

Goff Brian's History

Date Ticker Type Value
2026-04-02 AGIO M $0
2026-04-02 AGIO $433K
2026-04-02 AGIO M $0
2026-04-02 AGIO $229K
2026-04-02 AGIO M $0
2026-04-02 AGIO M $0
2025-12-30 AGIO M $0
2025-12-30 AGIO $338K
2025-12-30 AGIO M $0
2025-12-30 AGIO $169K

Other Insiders at AGIO (90d)

Insider Bought Sold Last
Goff Brian
Chief Executive Officer
$662K 2026-04-02
Jones Cecilia
Chief Financial Officer
$109K 2026-04-02
Gheuens Sarah
Chief Medical Officer
$102K 2026-04-02
Burns James William
Chief Legal Officer
$114K 2026-04-02
Milanova Tsveta
Chief Commercial Officer
$113K 2026-04-02
Viswanadhan Krishnan
Chief Corp Dev & Strategy
$103K 2026-04-02